{"slideshow_credits": null, "snippet": "The verdict is the first time a jury has decided such a case since the Supreme Court ruled last year that so-called pay-for-delay settlements may run afoul of antitrust laws.", "abstract": null, "section_name": "Business Day", "print_page": "", "document_type": "article", "byline": {"person": [], "organization": "REUTERS", "original": "By REUTERS", "contributor": ""}, "web_url": "http://www.nytimes.com/2014/12/06/business/astrazeneca-and-ranbaxy-win-in-antitrust-trial.html", "lead_paragraph": "The verdict is the first time a jury has decided such a case since the Supreme Court ruled last year that so-called pay-for-delay settlements may run afoul of antitrust laws.", "headline": {"main": "AstraZeneca and Ranbaxy Win in Antitrust Trial", "print_headline": "Astrazeneca And Ranbaxy Win In Antitrust Trial", "content_kicker": "Business Briefing"}, "_id": "5482671b38f0d8403d9cc333", "word_count": "98", "multimedia": [], "pub_date": "2014-12-06T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Antitrust Laws and Competition Issues", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "Courts and the Judiciary", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "AstraZeneca PLC", "name": "organizations", "is_major": "N", "rank": "3"}, {"value": "Ranbaxy Laboratories", "name": "organizations", "is_major": "N", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "Brief"}